Patent 6,630,507, titled “Cannabinoids as antioxidants and neuroprotectants,” was issued on Oct. 7, 2003 issued to the United States Department of Health and Human Services. The cannabinoids are found to have particular application as neuroprotectants, for example in limiting neurological damage following ischemic insults, such as stroke and trauma, or in the treatment of neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease and HIV dementia - SO WHY IS IT STILL ON SCHEDULE 1??? :: Soluna668 -++- STRAINS ON SALE UNTIL June 30th: Denali (DEN) - Durban-Poison-Punch (DPP) - Hash-Passion (HP) - Jesus-OG (JOG) - Kona (KON) -